NEOXENE 10 OV VAG 10MG

NEOXENE 10 MG OVULI

active ingredients

Each egg contains: Active ingredient: CLOREXIDINA DIGLUCONATO mg 10. Excipients: Propileparahydroxybenzoate, Etileparahydroxybenzoate. For the full list of excipients, see paragraph 6.1

Excellent

Glycerin, Gelatin, Propile parahydroxybenzoato, Etile parahydroxybenzoato, Blue Patent (E 131), Purified water.

Therapeutic indications

Vaginal mucosa disinfection.

Contraindications

Hypersensitivity to the active ingredient or any of the excipients.

Population

One, maximum two eggs per day for a maximum duration of ten consecutive days. DON'T OVERDO IT.

Conservation

Do not store at temperature above 25 °C Store in the original packaging to protect the medicine from light.

Warnings

Do not use for prolonged treatments. After a short period of treatment without appreciable results consult your doctor. Ingestion or accidental inhalation of some disinfectants may have serious, sometimes fatal consequences. Prolonged use of topical products can give rise to awareness-raising phenomena; in this case interrupt the treatment and consult the doctor to establish a suitable therapy. Neoxene is for only vaginal use and should not be ingested. After the application of Neoxene it is recommended to wash hands, in case of contact with the eyes rinse immediately with abundant water. This medicine contains Propileparahydroxybenzoate, Etileparahydroxybenzoate as excipients therefore can be slightly irritating to the skin, eyes and mucous membranes. Keep the medicine out of reach of children.

Interactions

Avoid the contemporary use of other antiseptics and detergents.

Effects

In some cases, intolerance (burning or irritation) may occur, however, without consequences, which does not require modification of treatment. Some rare cases of idiosyncrasia were reported against chlorhexidine. Reporting of suspicious adverse reactions. The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address www.agenziafarmaco.gov.it/it/responsabili.

Overdosing

Overdose cases have not been reported until now.

The medicine should only be used in case of actual need, under the direct control of the doctor.

Source: Farmadati